相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages
Jayant K. Rane et al.
EUROPEAN UROLOGY (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy- naive Metastatic Castration-resistant Prostate Cancer Patients
Arun A. Azad et al.
EUROPEAN UROLOGY (2015)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J. Ryan et al.
LANCET ONCOLOGY (2015)
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Monica Cojoc et al.
SEMINARS IN CANCER BIOLOGY (2015)
Cancer stem cells, cancer cell plasticity and radiation therapy
Erina Vlashi et al.
SEMINARS IN CANCER BIOLOGY (2015)
Enzalutamide for patients with metastatic castration-resistant prostate cancer
Wijdan H. Ramadan et al.
ONCOTARGETS AND THERAPY (2015)
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
Xin Liu et al.
ONCOTARGET (2015)
CRISPR/Cas9-mediated gene knockout of NANOG and NANOGP8 decreases the malignant potential of prostate cancer cells
Norihiko Kawamura et al.
ONCOTARGET (2015)
Androgen Receptor Splice Variants Contribute to Prostate Cancer Aggressiveness Through Induction of EMT and Expression of Stem Cell Marker Genes
Dejuan Kong et al.
PROSTATE (2015)
A switch from CD44+ cell to EMT cell drives the metastasis of prostate cancer
Zhiqun Shang et al.
ONCOTARGET (2015)
Novel drugs targeting the androgen receptor pathway in prostate cancer
Joaquin Mateo et al.
CANCER AND METASTASIS REVIEWS (2014)
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Rhonda L. Bitting et al.
CANCER AND METASTASIS REVIEWS (2014)
Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
Anne Schroeder et al.
CANCER RESEARCH (2014)
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation
D. Pellacani et al.
CELL DEATH AND DIFFERENTIATION (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Wnt signaling in adult intestinal stem cells and cancer
Michaela Krausova et al.
CELLULAR SIGNALLING (2014)
Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone
Salvatore Luca Burgio et al.
ENDOCRINE-RELATED CANCER (2014)
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
D. Bianchini et al.
EUROPEAN JOURNAL OF CANCER (2014)
Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
Andres Jan Schrader et al.
EUROPEAN UROLOGY (2014)
Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
Prabhakar Rajan et al.
EUROPEAN UROLOGY (2014)
Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response
Judy Yan et al.
EXPERIMENTAL CELL RESEARCH (2014)
Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer
Barbara Kahn et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Evolution of androgen receptor targeted therapy for advanced prostate cancer
Yien Ning Sophia Wong et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
J. L. L. Robinson et al.
ONCOGENE (2014)
Inhibition of Constitutively Active Stat3 Reverses Enzalutamide Resistance in LNCaP Derivative Prostate Cancer Cells
Chengfei Liu et al.
PROSTATE (2014)
Beyond the Androgen Receptor: New Approaches to Treating Metastatic Prostate Cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting
Kenneth J. Pienta et al.
PROSTATE (2014)
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
Vincenza Conteduca et al.
PROSTATE (2014)
The Pluripotency Factor Nanog Is Directly Upregulated by the Androgen Receptor in Prostate Cancer Cells
Steven Kregel et al.
PROSTATE (2014)
STEM CELL PLASTICITY Plasticity of epithelial stem cells in tissue regeneration
Cedric Blanpain et al.
SCIENCE (2014)
Immunohistochemical expression of four different stem cell markers in prostate cancer: High expression of NANOG in conjunction with hypoxia-inducible factor-1α expression is involved in prostate epithelial malignancy
Katsuhito Miyazawa et al.
ONCOLOGY LETTERS (2014)
Symmetrical and asymmetrical division analysis provides evidence for a hierarchy of prostate epithelial cell lineages
Jia Wang et al.
NATURE COMMUNICATIONS (2014)
Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells
Ying-Chu Lin et al.
STEM CELL RESEARCH & THERAPY (2014)
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention
Mannan Nouri et al.
FRONTIERS IN ONCOLOGY (2014)
SOX2 and cancer: current research and its implications in the clinic
Kasia Weina et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
K. L. Noonan et al.
ANNALS OF ONCOLOGY (2013)
The role of intratumoral and systemic IL-6 in breast cancer
Christine Dethlefsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
HDAC inhibitor confers radiosensitivity to prostate stem-like cells
F. M. Frame et al.
BRITISH JOURNAL OF CANCER (2013)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells
Paula Kroon et al.
CANCER RESEARCH (2013)
Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
Lei-Ya Fang et al.
CANCER RESEARCH (2013)
A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
Nicholas Mitsiades
CANCER RESEARCH (2013)
Generation of Prostate Tumor-Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling
Yi Qu et al.
CANCER RESEARCH (2013)
Progress in emerging therapies for advanced prostate cancer
Stephane Oudard
CANCER TREATMENT REVIEWS (2013)
MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway
I-Shan Hsieh et al.
CARCINOGENESIS (2013)
SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells
Adrian P. Rybak et al.
CELLULAR SIGNALLING (2013)
Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression
Eric Levesque et al.
CLINICAL CANCER RESEARCH (2013)
Cancer stem cells as 'units of selection'
Mel Greaves
EVOLUTIONARY APPLICATIONS (2013)
Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6
Jen-Tsun Lin et al.
EXPERIMENTAL CELL RESEARCH (2013)
Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9® Lead to Promotion versus Suppression of Prostate Cancer Metastasis
Tzu-Hua Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
Murielle Mimeault et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Activation of the Wnt Pathway through AR79, a GSK3β Inhibitor, Promotes Prostate Cancer Growth in Soft Tissue and
Yuan Jiang et al.
MOLECULAR CANCER RESEARCH (2013)
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
Zhu A. Wang et al.
NATURE CELL BIOLOGY (2013)
Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer
Steven Kregel et al.
PLOS ONE (2013)
Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines
Daniel Seiler et al.
PROSTATE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
T-H Lin et al.
CELL DEATH & DISEASE (2013)
Opposing Effects of Androgen Deprivation and Targeted Therapy on Prostate Cancer Prevention
Shidong Jia et al.
CANCER DISCOVERY (2013)
Molecular Classification of Prostate Cancer Progression: Foundation for Marker-Driven Treatment of Prostate Cancer
Christopher J. Logothetis et al.
CANCER DISCOVERY (2013)
Interplay Between Genomic Alterations and Androgen Receptor Signaling During Prostate Cancer Development and Progression
Michael D. Nyquist et al.
HORMONES & CANCER (2013)
Epigenomic Alterations in Localized and Advanced Prostate Cancer
Pei-Chun Lin et al.
NEOPLASIA (2013)
An APC: NT counter-current-like mechanism regulates cell division along the human colonic crypt axis: a mechanism that explains how APC mutations induce proliferative abnormalities that drive colon cancer development
Bruce M. Boman et al.
FRONTIERS IN ONCOLOGY (2013)
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
Martin Puhr et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells
Josep Domingo-Domenech et al.
CANCER CELL (2012)
Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk
Erika M. Kwon et al.
CANCER EPIDEMIOLOGY (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
Nicholas Mitsiades et al.
CANCER RESEARCH (2012)
The PSA-/Io Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
Jichao Qin et al.
CELL STEM CELL (2012)
Molecular genetics of prostate cancer: emerging appreciation of genetic complexity
Christopher E. Barbieri et al.
HISTOPATHOLOGY (2012)
Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration
Antonella De Luca et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+Breast Cancer by Expanding the Cancer Stem Cell Population
Hasan Korkaya et al.
MOLECULAR CELL (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sox2 expression in breast tumours and activation in breast cancer stem cells
O. Leis et al.
ONCOGENE (2012)
Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases
Marc Colombel et al.
PROSTATE (2012)
Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer
Markus Germann et al.
STEM CELLS (2012)
Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells
Adrian P. Rybak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu et al.
CANCER RESEARCH (2011)
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
Li Lin et al.
CANCER RESEARCH (2011)
Sox2+ Adult Stem and Progenitor Cells Are Important for Tissue Regeneration and Survival of Mice
Katrin Arnold et al.
CELL STEM CELL (2011)
FOXA1: master of steroid receptor function in cancer
Michael A. Augello et al.
EMBO JOURNAL (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CYP17 inhibitors for prostate cancer therapy
Tadas S. Vasaitis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
C. R. Jeter et al.
ONCOGENE (2011)
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
Akash Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
Dimitrios Iliopoulos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
Mohamed Salem et al.
CURRENT ONCOLOGY REPORTS (2011)
Plasma chromogranin A: Clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy
Debansu Sarkar et al.
CANCER BIOMARKERS (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1 alpha Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
Carol L. Nilsson et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Michael C. Haffner et al.
NATURE GENETICS (2010)
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Hiroshi Tanaka et al.
NATURE MEDICINE (2010)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics
Isabelle Bisson et al.
CELL RESEARCH (2009)
Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
George J. Klarmann et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Teruhisa Kawamura et al.
NATURE (2009)
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Rosa M. Marion et al.
NATURE (2009)
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Jochen Utikal et al.
NATURE (2009)
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Han Li et al.
NATURE (2009)
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Wennuan Liu et al.
NATURE MEDICINE (2009)
Selective Expression of CD44, a Putative Prostate Cancer Stem Cell Marker, in Neuroendocrine Tumor Cells of Human Prostate Cancer
Ganesh S. Palapattu et al.
PROSTATE (2009)
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Ram-Shankar Mani et al.
SCIENCE (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
Current status of experimental therapeutics for prostate cancer
Chulso Moon et al.
CANCER LETTERS (2008)
Crosstalk between the Androgen Receptor and beta-Catenin in Castrate-Resistant Prostate Cancer
Gang Wang et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells
Hongzhen Li et al.
EXPERIMENTAL CELL RESEARCH (2008)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
Dominik R. Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
L. Tam et al.
BRITISH JOURNAL OF CANCER (2007)
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer
Elahe A. Mostaghel et al.
CANCER RESEARCH (2007)
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo
Guangyu Gu et al.
CANCER RESEARCH (2007)
The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression
Meletios Verras et al.
CANCER RESEARCH (2007)
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Jun Miki et al.
CANCER RESEARCH (2007)
The androgen receptor in prostate cancer: Therapy target in search of an integrated diagnostic test
Jeffrey S. Ross
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells
L Patrawala et al.
ONCOGENE (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells
WJ Huss et al.
CANCER RESEARCH (2005)
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
A Berruti et al.
ENDOCRINE-RELATED CANCER (2005)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
RB Shah et al.
CANCER RESEARCH (2004)
Adrenal androgens and intracrinology
F Labrie
SEMINARS IN REPRODUCTIVE MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
J Edwards et al.
BRITISH JOURNAL OF CANCER (2003)
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
MP Roudier et al.
HUMAN PATHOLOGY (2003)
Prostate cancer: A brief history and the discovery of hormonal ablation treatment
B Lytton
JOURNAL OF UROLOGY (2001)
Epigenetic regulation of androgen receptor gene expression in human prostate cancers
T Nakayama et al.
LABORATORY INVESTIGATION (2000)
分享论文
